その他／医薬品の求人・転職情報

Job Purpose:

At GSK, we are uniting science, technology, and talent to get ahead of disease together. The RWE-HO Associate Director/ Scientist drives the development and execution of real-world evidence strategies and health outcomes research to demonstrate the value of GSK's medicines and vaccines in alignment with access, reimbursement, and lifecycle management goals. This role works in a matrix environment with local and global teams to ensure impactful evidence generation to inform payer, clinical decision-making, leading to successful patient access.



Key Responsibilities:

The role reports to the Director of RWE-HO and provides scientific leadership for one or more assigned asset(s), applying expertise in real-world evidence and other non-interventional study methodologies. The role serves as Lead of the Japan Data Generation Team (J-DGT) and is an active member of relevant local and global matrix data generation teams. The RWE-HO Associate Director/ Scientist is accountable for close partnership with Medical and cross-functional stakeholders and for driving the planning, design, delivery, translation, and dissemination of asset-level data generation plans (DGPs) in alignment with global evidence strategies.



• Lead the planning, design, and delivery of medical, real-world evidence, and health economics studies for assigned asset(s), managing timelines, deliverables, and budgets across the asset lifecycle.

• Develop and own the asset-level HTA and/or National Immunisation Program (NIP) evidence strategy, aligned with Government Affairs & Market Access (GAMA) and global access principles, in close collaboration with local and global Evidence Synthesis and Modelling teams for execution.

• Provide scientific leadership and governance oversight to ensure high-quality, compliant delivery of protocols, analysis plans, study reports, publications, and other evidence outputs in line with SOPs.

• Translate strategic evidence needs into fit-for-purpose study concepts aligned with asset strategy and lifecycle priorities, including innovative and cost-effective study approaches.

• Identify, evaluate, and leverage appropriate real-world data sources, partnerships, and public initiatives to address prioritized research questions.

• Act as a scientific partner to cross-functional stakeholders (Medical, Market Access, R&D, Commercial), providing evidence-based input to support asset decision-making.

• Demonstrate effective matrix leadership by influencing across functions and geographies, contributing to cross-asset alignment, and providing scientific guidance and mentoring to junior team members and matrix partners as appropriate.

• Monitor the external environment, including RWE/HEOR methodological, data, and policy developments, and engage external experts as appropriate in line with GSK governance.

1.自社の医薬情報担当者（MR）に対する教育研修の企画立案～実施
2.自社医薬品のプロモーション用資材全般に関する企画立案～作成
3.自社医薬品の製品関連サイトに関する企画立案～開設、メンテナンス
4.主要学会をはじめとする主催および共催講演会等の企画立案～実施
5.KOL-Drとのリレーション構築支援
6.自社の医薬情報担当者（MR）に対する学術支援（医療関係者への面談同行等）
7.MR認定証管理に関する一切の業務（MR認定センター：MR要綱に準拠）
8.所属部門スタッフのマネジメント管理

Job purpose:

Reporting to the Evidence Strategy & Operations Lead, this role operates across therapeutic areas to deliver payer‑focused evidence generation, drive HEOR activities for priority assets.  The role has a strong HTA focus and will drive HTA submission projects, prioritising evidence packages and dossier development to meet local HTA and reimbursement requirements; coordinate evidence generation, modelling and stakeholder engagement; and provide HTA‑specific scientific and strategic input to secure favourable access outcomes.



Key Responsibilities:

Evidence synthesis & health economics

Lead health economics projects to generate high quality and timely data to support the access of prioritised brands to the Japan market, including leading and executing evidence synthesis activities: systematic literature reviews (SLRs), targeted literature reviews (TLRs) and meta-analyses to support HTA, economic models and payer evidence needs.

Responsible for the development and delivery of Japan health technology assessment (HTA) submissions including development and agreement of strategy, liaison with internal and external senior stakeholders and the reimbursement bodies.

Input into pricing decisions for brands to ensure that cost effectiveness is appropriately considered in decision making.

Collaborate with Asset Leads in Japan and Global Real-World Evidence & Health Outcomes Research (RWE-HO), local cross-functional teams, including Government Affairs & Market Access (GAMA), regulatory and development to ensure payer/ value evidence are developed with a full understanding of the requirements of Japan health system/ policy landscape.



Capability building & stakeholder engagement

Build relationships with HTA bodies, payer advisors, clinical experts, and academic institutions to ensure external relevance and scientific credibility.

Monitor healthcare policy, HTA trends, and competitive landscape to inform proactive evidence planning.

Drive discipline in performance reporting and ensure studies are delivered according to plan and within budget.

Champion the role and value of HEOR internally, increasing understanding across functions on how evidence supports access and adoption.

主にコマーシャル組織（特にMR）向けの研修プログラムの開発と実施を担当して頂きます。
本ポジションは、製品知識を向上させ、営業チームが製品および医学情報を効果的に伝達できるようにすることを目的としています。

【職務内容】
スワインカスタマーチームマネージャーとして、担当エリアの目標を達成するため、チーム全体の豚用医薬品（ワクチン、抗菌剤、ホルモン剤など）の売上最大化に向けてリードし、統括管理するとともにその責任を負う。

水産や畜産向けワクチン、抗菌剤、動物用医薬品などの研究開発業務
・動物用医薬品等に関わる製品開発及び各種試験、データのまとめ
・薬事に関する申請資料の作成
・試験魚の飼育など

水産、畜産関係の飼料メーカーから販売代理店、養殖業者や畜産農家にいたる様々な顧客ニーズに合わせた研究開発を担っていただきます。